Literature DB >> 2440690

L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease.

M Hontebeyrie-Joskowicz, G Said, G Milon, G Marchal, H Eisen.   

Abstract

During the chronic phase of infection with the parasite Trypanosoma cruzi, mice develop inflammatory lesions in the heart and skeletal muscles, as well as in peripheral nerves and the liver. We demonstrated the presence, in the blood of chronically infected mice, of L3T4+ T cells able to transfer a specific T. cruzi delayed-type hypersensitivity (DTH) reaction. Transfer of the chronic inflammatory lesions was obtained by injecting Lyt-2+-depleted lymphocytes from either lymph node or blood of infected mice. T cell lines were established from the chronically infected mice by culturing peripheral blood lymphocytes or lymph node cells with either T. cruzi extracts (TC) or mouse peripheral nerve extracts (PN). Those cell lines that presented an L3T4+ phenotype were also able to specifically transfer a local DTH reaction to naive recipients. Examination of the antigen specificities of these TDTH lines revealed three types: those that mediated a DTH reaction to TC, those that responded to both TC and PN and those that provoked a DTH response when injected with subinflammatory doses of an irrelevant antigen. Some of the lines, when injected into the sciatic nerve of naive recipients, provoked demyelination of the type observed in chronically infected animals. These results suggest that T. cruzi and the host nervous system share common epitopes that can be recognized by TDTH cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440690     DOI: 10.1002/eji.1830170720

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon.

Authors:  C A Hunter; T Slifer; F Araujo
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 4.  Parasite heat-shock proteins and host responses: the balance between protection and immunopathology.

Authors:  D Mazier; D Mattei
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Identification and partial characterization of Trypanosoma cruzi antigens recognized by T cells and immune sera from patients with Chagas' disease.

Authors:  R T Gazzinelli; V M Leme; J R Cancado; G Gazzinelli; J Scharfstein
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

Review 6.  Hot topics in adeno-associated virus as a gene transfer vector.

Authors:  N Zhao; D P Liu; C C Liang
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

7.  Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease.

Authors:  R L Tarleton; J Sun; L Zhang; M Postan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope.

Authors:  E A Mesri; G Levitus; M Hontebeyrie-Joskowicz; G Dighiero; M H Van Regenmortel; M J Levin
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

9.  Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease.

Authors:  M R Grauert; M Houdayer; M Hontebeyrie-Joskowciz
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

10.  Circulating antibodies against nicotinic acetylcholine receptors in chagasic patients.

Authors:  J C Goin; G Venera; M Biscoglio de Jiménez Bonino; L Sterin-Borda
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.